GovChime
Notice ID: 91da9def5e004a94b0a8e4c2b8600f1dPresolicitationArchived

Digital Just for Mouse Stereotaxic Instruments

Archived on July 3, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
11:00 PM EDT
Posted
June 24, 2026
Notice type
Presolicitation
Set-aside
Small Business Set Aside - Total
NAICS
339112: Surgical and Medical Instrument Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH OLAO
Place of performance
Bethesda, 20892
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75N98026Q00702
Notice ID
91da9def5e004a94b0a8e4c2b8600f1d

Description

Attachment: Notice of Intent

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (1)

  • Notice of Intent.pdf

    28 KBAdded in Presolicitation version 3Posted
    Download

Lifecycle

  1. 3
    Version 3PresolicitationArchivedCurrent

    Digital Just for Mouse Stereotaxic Instruments

    Notice 91da9def5e004a94b0a8e4c2b8600f1d on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Bard Peripheral Vascular Inc. Acquisition Description: Procurement of BD Mission™ Disposable Core Biopsy Instrument (semi-automatic, single-use) for use in Interventional Radiology image-guided core needle biopsy procedures. Device is compatible with the BD TruGuide™ Disposable Coaxial Biopsy Needle and is available in 14G–20G gauges and 6–25 cm lengths to accommodate a range of lesion depths and target sites. Features include Advanced Echogenic Technology for enhanced ultrasound visibility, a Fire Ready Indicator, and a penetration depth indicator (10mm/20mm presets). Core Function: Supplies required: BD Mission™ Disposable Core Biopsy Instrument(s), single-use, sterile, for IR core needle biopsy procedures. Delivery is requested on an as-needed/recurring basis via standard vendor shipment The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000988) by 12:00 PM eastern standard time on 11/08/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
75%
Pre-Solicitation11/08/2026
The National Institute on Aging (NIA), Intramural Research Program (IRP), operates the Clinical Research Unit (CRU) located at the MedStar Harbor Hospital campus in Baltimore, Maryland. The CRU serves as the primary dedicated clinical facility supporting human longitudinal and translational aging research protocols, including the Baltimore Longitudinal Study of Aging (BLSA), the Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT) study, and specialized clinical trials investigating age-related functional decline and metabolic disorders. A cornerstone of these intramural clinical protocols involves invasive outpatient biopsy procedures—specifically percutaneous skeletal muscle biopsies, subcutaneous adipose tissue biopsies, and dermal skin punch biopsies. These procedures provide vital biospecimens for cellular, molecular, and physiological characterization of human aging. The existing ceiling-mounted surgical lighting system currently deployed in the CRU procedure suite has reached the end of its useful service life (End-of-Life / EOL). The legacy unit is experiencing persistent operational failures. Critical replacement parts are no longer manufactured or supported by the original equipment manufacturer (OEM), rendering the existing unit non-serviceable. Because medical-grade illumination is a non-negotiable safety and operational prerequisite for procedural asepsis, precise anatomical depth perception, tissue differentiation, and hemostasis, the current state presents an unacceptable clinical risk and threatens immediate disruption to approved NIA protocol timelines.
75%
Market Research12/08/2026
See attached solicitation for METRx Instruments OR Equal. This is a brand name or equal solicitation with small business set aside IAW RFO Part 12. Please see Addendum to 52.212-1 Instructions to Offerors and 52.212-2 Evaluation for important information on submitting your quote and how quotes will be evaluated.
71%
Combined Synopsis11/13/2026
This acquisition is for a software maintenance agreement between Agilent and the National Institutes of Health Clinical Center for the existing Agilent OpenLab/ECM data system. • Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies • NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing • Place of Performance: Bethesda, MD 20892 USA POTS: 27-000218 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Agilent Technologies, located at 2850 Centerville Rd, Wilmington, Delaware, on a firm fixed price sole source award basis to provide the required software maintenance agreement to the National Institutes of Health. Agilent Technologies is the proposed vendor for this acquisition because Agilent Technologies is the designer/manufacturer of all the existing analytical equipment/software in the NIH Clinical Center PET Department. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by November 23rd, 2026 at 12pm EST.
69%
Special Notice11/23/2026
This acquisition is for an Advance Plan Plus Service Agreement for the Siemens Biograph mCT PET/CT at the Radiology and Imaging Sciences Department at the National Institutes of Health Clinical Center. • Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies • NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing • Place of Performance: Bethesda, MD 20892 USA POTS: 27-000798 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Siemens Medical Solutions USA Inc, located at 40 Liberty Blvd, Malvern, PA, on a firm fixed price sole source award basis to provide the required service agreement to the National Institutes of Health. PET/CT scanners require Original Equipment Manufacturer (OEM) service agreements to ensure optimal performance, image quality, and maximize equipment uptime. The unique benefits of OEM service coverage includes the following: 24/7 Remote Diagnostics and Monitoring: Continuous system tracking via Siemens' proprietary SRS (Siemens Remote Service) portal. Proprietary Software Updates: Delivery and installation of mandatory safety patches, software revisions, and system licensing upgrades. Certified OEM Hardware Support: Access to proprietary replacement parts, including Straton x-ray tubes and LSO crystal detector blocks, engineered specifically for the Biograph mCT platform. Factory-Trained Engineering: On-site preventative maintenance and emergency repairs performed exclusively by Siemens Healthineers certified field engineers. The existing Siemens Biograph mCT PET/CT installed in RADIS room 1C-488 uses proprietary technology and is best serviced and maintained by the original equipment manufacturer (i.e., Siemens Medical Solutions USA, Inc.). This service agreement is required to ensure the Radiology department continues to deliver high-quality PET/CT scans to patients while minimizing equipment downtime. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by November 27, 2026 at 12pm EST.
69%
Special Notice11/27/2026

Additional Details

Solicitation Number

75N98026Q00702

Archive Date

Jul 3, 2026

Office Address

BETHESDA, MD, 20892